Dimemorfan
|
WikiDoc Resources for Dimemorfan |
|
Articles |
|---|
|
Most recent articles on Dimemorfan |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Dimemorfan at Clinical Trials.gov Clinical Trials on Dimemorfan at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Dimemorfan
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Dimemorfan Discussion groups on Dimemorfan Patient Handouts on Dimemorfan Directions to Hospitals Treating Dimemorfan Risk calculators and risk factors for Dimemorfan
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Dimemorfan |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Dimemorfan is an antitussive or cough suppressant which acts as a sigma receptor agonist.It is an analogue of dextromethorphan and dextrorphan, but lacks significant NMDA receptor antagonistic action and dissociative effects, thereby having reduced abuse potential and adverse effects in comparison.
